Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · IEX Real-Time Price · USD
5.80
-0.13 (-2.19%)
At close: Jul 19, 2024, 4:00 PM
5.76
-0.04 (-0.69%)
Pre-market: Jul 22, 2024, 7:32 AM EDT

Sana Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
CurrentDec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Market Capitalization
1,2858047532,923--
Market Cap Growth
252.29%6.76%-74.23%---
Enterprise Value
1,0766994322,483-308-93
PE Ratio
--2.84-2.80-8.21--
PB Ratio
3.422.801.514.01--
P/FCF Ratio
-8.06-2.94-2.42-10.41--
P/OCF Ratio
-9.19-3.17-2.60-11.64--
EV/EBITDA Ratio
-7.35-2.85-1.79-7.351.120.69
EV/EBIT Ratio
-6.47-2.47-1.60-6.981.080.67
EV/FCF Ratio
-7.29-2.56-1.39-8.841.910.83
Debt / Equity Ratio
0.280.360.220.15-0.17-0.33
Debt / EBITDA Ratio
-0.39-0.42-0.45-0.33-0.26-0.35
Debt / FCF Ratio
-0.39-0.38-0.35-0.39-0.44-0.43
Quick Ratio
5.953.243.865.5512.107.28
Current Ratio
6.073.313.995.6212.227.47
Return on Equity (ROE)
-89.20%-78.90%-44.80%-42.50%101.20%168.00%
Return on Assets (ROA)
-47.70%-42.70%-28.80%-28.90%-49.80%-58.20%
Return on Capital (ROIC)
-66.46%-74.86%-44.86%-42.52%81.93%148.83%
Earnings Yield
-24.02%-35.22%-35.77%-12.18%--
FCF Yield
-21.30%-34.02%-41.27%-9.61%--
Buyback Yield / Dilution
-13.63%-3.29%-13.17%-1178.88%-165.43%-414.97%
Total Shareholder Return
-13.63%-3.29%-13.17%-1178.88%-165.43%-414.97%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).